CANCER AND CAPITALISM:
Who Will Stand Guard in the Cancer Wars?

In the age of genomic discovery, there have been exponential advances in molecular science and development of targeted therapies, but government support of medical research (particularly funding to the National Cancer Institute) has decreased significantly over time. With the pharmaceutical industry in the driver’s seat for research, what does this portend for progress in the war on cancer?

Dr. Larry Norton presented the latest developments in the fight against breast cancer, followed by the program

Moderator
Hon. Helen Freedman, NYS App. Div. 1st Dep’t (Retired)

Panel of Judges
Hon. Ellen Gesmer, NYS App. Div. 1st Dep’t
Hon. Karla Moskowitz, NYS App. Div. 1st Dep’t (Retired)
Hon. Alan Scheinkman, Presiding Justice, NYS App. Div. 2d Dep’t

Panel of Experts
Larry Norton, MD, Deputy Physician-in-Chief for Breast Cancer Programs, Memorial Sloan Kettering Cancer Center
Mace Rothenberg, MD, Chief Development Officer, Oncology, Pfizer Global Product Development, Pfizer Inc.
Fran Visco, President, National Breast Cancer Coalition

Sponsor
The Ellen P. Hermanson Foundation

Supporting Organizations (List in Formation)
New York City Bar Association Health Law Committee
Women’s Bar Association of the State of New York

Symposium Co-Chairs
Hon. Shirley Werner Kornreich, Mikki Golar, Esq., Barbara A. Ryan, Esq.